EcoDrugPlus

Prostaglandin D2 Receptor 2

Ensembl ID : ENSNFUG00015001142
Gene Symbol: PTGDR2
3 Cross references
135 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSNFUG00015006524
Gene Symbol: PTGER1A
1 Cross references
167 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSNFUG00015024017
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSNFUG00015003122
Gene Symbol: LOC107376169
3 Cross references
164 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSNFUG00015002076
Gene Symbol: LOC107381029
3 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSNFUG00015012249
Gene Symbol: LOC107374924
3 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSNFUG00015010865
Gene Symbol: LOC107394131
3 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSNFUG00015014143
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin G/h Synthase 1-Like

Ensembl ID : ENSNFUG00015003556
Gene Symbol: LOC107374754
3 Cross references
182 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSNFUG00015010329
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSNFUG00015017519
Gene Symbol: PTGS1
1 Cross references
212 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSNFUG00015007867
Gene Symbol: PTGS2B
1 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).